Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Human telomerase reverse transcriptase peptide (611-626)

EU orphan designation number: EU/3/06/384   
Active ingredient: Human telomerase reverse transcriptase peptide (611-626)
Indication: Treatment of pancreatic cancer
Sponsor: Gemvax A/S
Drammensveien 100, N-0273 Oslo, Norge

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2006 Centralised Orphan - Designation EMEA/OD/026/06 (2006)3431 of 25/07/2006
21/07/2008 Other procedure EMEA/OD/026/06
28/05/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/026/06/T/01 (2009)4226 of 26/05/2009
22/09/2009 Corrigendum (2009)6035 of 24/07/2009